Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.

Drug-target interaction (DTI) is a key aspect in pharmaceutical research. With the ever-increasing new drug data resources, computational approaches have emerged as powerful and labor-saving tools in predicting new DTIs. However, so far, most of these predictions have been based on structural simila...

Full description

Bibliographic Details
Main Authors: Lei Chen, Chen Chu, Jing Lu, Xiangyin Kong, Tao Huang, Yu-Dong Cai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4423955?pdf=render
_version_ 1818275537795153920
author Lei Chen
Chen Chu
Jing Lu
Xiangyin Kong
Tao Huang
Yu-Dong Cai
author_facet Lei Chen
Chen Chu
Jing Lu
Xiangyin Kong
Tao Huang
Yu-Dong Cai
author_sort Lei Chen
collection DOAJ
description Drug-target interaction (DTI) is a key aspect in pharmaceutical research. With the ever-increasing new drug data resources, computational approaches have emerged as powerful and labor-saving tools in predicting new DTIs. However, so far, most of these predictions have been based on structural similarities rather than biological relevance. In this study, we proposed for the first time a "GO and KEGG enrichment score" method to represent a certain category of drug molecules by further classification and interpretation of the DTI database. A benchmark dataset consisting of 2,015 drugs that are assigned to nine categories ((1) G protein-coupled receptors, (2) cytokine receptors, (3) nuclear receptors, (4) ion channels, (5) transporters, (6) enzymes, (7) protein kinases, (8) cellular antigens and (9) pathogens) was constructed by collecting data from KEGG. We analyzed each category and each drug for its contribution in GO terms and KEGG pathways using the popular feature selection "minimum redundancy maximum relevance (mRMR)" method, and key GO terms and KEGG pathways were extracted. Our analysis revealed the top enriched GO terms and KEGG pathways of each drug category, which were highly enriched in the literature and clinical trials. Our results provide for the first time the biological relevance among drugs, targets and biological functions, which serves as a new basis for future DTI predictions.
first_indexed 2024-12-12T22:31:20Z
format Article
id doaj.art-2447f6473e76479eac3fa21e6310b4ce
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T22:31:20Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2447f6473e76479eac3fa21e6310b4ce2022-12-22T00:09:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012649210.1371/journal.pone.0126492Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.Lei ChenChen ChuJing LuXiangyin KongTao HuangYu-Dong CaiDrug-target interaction (DTI) is a key aspect in pharmaceutical research. With the ever-increasing new drug data resources, computational approaches have emerged as powerful and labor-saving tools in predicting new DTIs. However, so far, most of these predictions have been based on structural similarities rather than biological relevance. In this study, we proposed for the first time a "GO and KEGG enrichment score" method to represent a certain category of drug molecules by further classification and interpretation of the DTI database. A benchmark dataset consisting of 2,015 drugs that are assigned to nine categories ((1) G protein-coupled receptors, (2) cytokine receptors, (3) nuclear receptors, (4) ion channels, (5) transporters, (6) enzymes, (7) protein kinases, (8) cellular antigens and (9) pathogens) was constructed by collecting data from KEGG. We analyzed each category and each drug for its contribution in GO terms and KEGG pathways using the popular feature selection "minimum redundancy maximum relevance (mRMR)" method, and key GO terms and KEGG pathways were extracted. Our analysis revealed the top enriched GO terms and KEGG pathways of each drug category, which were highly enriched in the literature and clinical trials. Our results provide for the first time the biological relevance among drugs, targets and biological functions, which serves as a new basis for future DTI predictions.http://europepmc.org/articles/PMC4423955?pdf=render
spellingShingle Lei Chen
Chen Chu
Jing Lu
Xiangyin Kong
Tao Huang
Yu-Dong Cai
Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.
PLoS ONE
title Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.
title_full Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.
title_fullStr Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.
title_full_unstemmed Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.
title_short Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System.
title_sort gene ontology and kegg pathway enrichment analysis of a drug target based classification system
url http://europepmc.org/articles/PMC4423955?pdf=render
work_keys_str_mv AT leichen geneontologyandkeggpathwayenrichmentanalysisofadrugtargetbasedclassificationsystem
AT chenchu geneontologyandkeggpathwayenrichmentanalysisofadrugtargetbasedclassificationsystem
AT jinglu geneontologyandkeggpathwayenrichmentanalysisofadrugtargetbasedclassificationsystem
AT xiangyinkong geneontologyandkeggpathwayenrichmentanalysisofadrugtargetbasedclassificationsystem
AT taohuang geneontologyandkeggpathwayenrichmentanalysisofadrugtargetbasedclassificationsystem
AT yudongcai geneontologyandkeggpathwayenrichmentanalysisofadrugtargetbasedclassificationsystem